Sysmex (OTCMKTS:SSMXY) Shares Gap Down - Should You Sell?

Key Points

• Sysmex shares gapped down after closing at $12.90 and opening at $12.31, with a trading volume of 759 shares.
• Zacks Research upgraded Sysmex's rating from a "strong sell" to a "hold", reflecting a change in market sentiment towards the stock.
• The company's latest earnings missed analyst estimates, reporting $0.05 earnings per share against a forecast of $0.12, with quarterly revenue of $717.09 million falling short of expectations.

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $12.90, but opened at $12.31. Sysmex shares last traded at $12.31, with a volume of 759 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of "Hold".

Sysmex Stock Performance

The firm's 50 day moving average price is $14.95 and its 200-day moving average price is $16.90. The firm has a market cap of $8.10 billion, a price-to-earnings ratio of 25.73 and a beta of 1.10. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.37 and a quick ratio of 2.49.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). Sysmex had a return on equity of 10.20% and a net margin of 9.35%.The business had revenue of $717.09 million for the quarter, compared to analyst estimates of $807.27 million. On average, analysts anticipate that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.